Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Cormet Post-PMA Study: New Enrollment [NA]
Trial update for Corin's PMA study with new enrollment; study completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: Yoga as Self-Care for Arthritis in Minority Communities [NA]
A completed clinical trial evaluating yoga as self-care for arthritis in minority communities; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) [Phase 3]
A Phase 3 trial comparing CHS-0214 to Enbrel (Etanercept) in rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-26Clinical Trial Update: Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]
Phase 1/2 trial assessing pharmacokinetics and safety of GSK3196165 with methotrexate in Japanese patients with rheumatoid arthritis has com…
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects [Phase 4]
Phase 4 trial investigating how residual inflammation, drug levels, and patient factors influence dose tapering of adalimumab in rheumatoid …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Clinical trial update assessing the efficacy of etanercept over 12 months in routine treatment of rheumatoid arthritis and related inflammat…
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta [Phase 1]
Phase 1 postmarketing transfer study evaluating Cimzia (certolizumab pegol) from mother to infant via placenta has completed with results po…
-
CLINICAL_TRIALS trial_result · 2019-06-20Clinical Trial Update: Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid Arthritis [Phase 1, Phase 2]
Clinical trial update evaluating umbilical cord tissue-derived mesenchymal stem cells for rheumatoid arthritis across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2019-06-19Clinical Trial Update: An ObserVatIonal STudy of the Effectiveness of AdaLimumab on Health and Disability Outcomes in New Zealand Patients With Immune-Mediated InflammaTorY Diseases (VITALITY)
Completed observational trial evaluating the effectiveness of adalimumab on health and disability outcomes in immune-mediated inflammatory d…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis [Phase 3]
A Phase 3 comparative trial evaluating the efficacy and safety of BCD-055 versus Remicade in combination with methotrexate in active rheumat…
-
FDA approval · 2019-06-13FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
The FDA approved a supplemental application for AMJEVITA (adalimumab-atto) submitted by Nuvaila Limited.
-
FDA approval · 2019-06-11FDA Approved: ACTEMRA — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Actemra (tocilizumab) filed by Genentech, Inc., resulting in an approved update to the product's…
-
FDA approval · 2019-06-03FDA Approved: LEFLUNOMIDE — Original Application (KVK-Tech, Inc.)
FDA approves Leflunomide from KVK-Tech, Inc. via an Original Application (ANDA 212453). The product is indicated for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase 2 trial assessing the efficacy and safety of BMS-986142 in adults with moderate to severe rheumatoid arthritis has completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-05-28Clinical Trial Update: Metformin Use in Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update investigating metformin use in rheumatoid arthritis is ongoing (status unknown).
-
FDA approval · 2019-05-23FDA Approved: TRUXIMA — Supplemental Application (Cephalon, Inc.)
FDA approved a supplemental application for TRUXIMA (rituximab-ABBS) submitted by Cephalon, Inc.
-
CLINICAL_TRIALS trial_result · 2019-05-23Clinical Trial Update: Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Rheumatoid Arthritis Refractory to Methotrexate [Phase 2]
Phase 2 trial update evaluating fecal microbiota transplantation for efficacy and safety in rheumatoid arthritis refractory to methotrexate.
-
EMA safety_alert · 2019-05-17Restrictions in use of Xeljanz while EMA reviews risk of blood clots in lungs
The EMA announced restrictions on the use of Xeljanz (tofacitinib) while it reviews the risk of blood clots in the lungs, indicating potenti…
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing leflunomide alone versus two DMARD combinations for rheumatoid arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-13Clinical Trial Update: A Long Term Extension Study of WA19926 (NCT01007435) of Tocilizumab (RoActemra/Actemra) in Participants With Early, Moderate to Severe Rheumatoid Arthritis (RA) [Phase 3]
Long-term extension study of tocilizumab in early to moderate-severe rheumatoid arthritis completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-05-06Clinical Trial Update: Long-term Safety and Efficacy of Sirukumab in Participants With RA Completing Studies CNTO136ARA3002 or CNTO136ARA3003 [Phase 3]
Long-term safety and efficacy results for sirukumab in rheumatoid arthritis patients who completed prior phase 3 studies CNTO136ARA3002 or C…
-
FDA approval · 2019-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Harris Teeter)
FDA approved Harris Teeter's diclofenac sodium as a generic under an original ANDA.
-
FDA approval · 2019-05-03FDA Approved: DAYPRO — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Daypro (oxaprozin) from Pfizer Laboratories Div Pfizer Inc, advancing regulatory action rela…
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: The Standard Care Versus Celecoxib Outcome Trial [Phase 4]
A Phase 4 clinical trial comparing standard care with celecoxib in osteoarthritis and rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: REMission INDuction in Very Early Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial investigating REMission INDuction in very early rheumatoid arthritis has been terminated.